GOOD NEWS
BUYING TIME In what may be a breakthrough, researchers used early drug intervention to delay the onset of the autoimmune disorder multiple sclerosis. Doctors administered either a placebo or interferon beta-1a (Avonex) to 383 patients who had suffered one episode of symptoms--such as double or cloudy vision or problems with bladder control or balance--that often precede MS. Forty percent of the placebo group but less than 24% of the Avonex group developed MS over the course of the three-year study.
MENTAL FITNESS Another reason to get off the couch: researchers at Duke University Medical Center have shown that moderate...
To continue reading:
or
Log-In
